Atlas Trials

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Clinical trial NCT03120364 · COMPLETED

Trial details

NCT number
NCT03120364
Sponsor
SK Chemicals Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2015-09-09
Primary completion
2015-12-16
Enrollment
824

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.